Sarepta Therapeutics

YTD

ALL

Trade Sarepta Therapeutics 24 hours a day, five days a week on Robinhood.

Robinhood gives you the tools to revolutionize your trading experience. Use the streamlined mobile app, or access advanced charts and execute precise trades on our browser-based platform, Robinhood Legend. Risks and limitations apply.

About SRPT

Sarepta Therapeutics, Inc. is a commercial-stage biopharmaceutical company, which is engaged in the discovery and development of therapeutics for the treatment of rare diseases. The company was founded on July 22, 1980, and is headquartered in Cambridge, MA.

CEO

Douglas S. Ingram

CEODouglas S. Ingram

Employees

1,372

Employees1,372

Headquarters

Cambridge, Massachusetts

HeadquartersCambridge, Massachusetts

Founded

1980

Founded1980

Employees

1,372

Employees1,372

SRPT Key Statistics

Market cap

2.09B

Market cap2.09B

Price-Earnings ratio

-28.95

Price-Earnings ratio-28.95

Dividend yield

—

Dividend yield—

Average volume

6.77M

Average volume6.77M

High today

$21.82

High today$21.82

Low today

$20.92

Low today$20.92

Open price

$21.58

Open price$21.58

Volume

3.75M

Volume3.75M

52 Week high

$138.81

52 Week high$138.81

52 Week low

$10.42

52 Week low$10.42

SRPT News

Simply Wall St 4d

Sarepta Therapeutics: Evaluating Valuation After a Recent 23% Share Price Rebound

Sarepta Therapeutics (SRPT) shares have caught the attention of investors recently, especially as the stock's performance over the past month has shown a jump o...

Benzinga 7d

What's Going On Sarepta Stock On Wednesday?

Sarepta Therapeutics Inc. (NASDAQ:SRPT) stock is trading higher on Wednesday, with apparently no news to justify the movement. This week, Sarepta will present...

Analyst ratings

58%

of 26 ratings

Buy

23.1%

Hold

57.7%

Sell

19.2%

People also own

Based on the portfolios of people who own SRPT. This list is generated using Robinhood data, and it’s not a recommendation.